Vor Biopharma Inc. - Common Stock — 四半期財務統計 (NASDAQ:VOR) | MetaTrader

チャート全体を表示 Full chart

Financials

概要明細書統計

営業活動によるキャッシュフロー -24.06 M-31.07 M-35.18 M-53.66 M-22.8 M-38.25 M -149.89 M 投資活動によるキャッシュフロー -72 K-230 K646 K-244 K-48.97 M-263.24 M -311.81 M 財務活動によるキャッシュフロー 53.29 M-606 K175.06 M21.55 M307.8 M74.87 M 579.28 M フリーキャッシュフロー -24.06 M-31.07 M-35.34 M-53.91 M-23.11 M-38.29 M -150.65 M

ニュース

Wall Street Analysts Believe Vor Biopharma (VOR) Could Rally 124.59%: Here's is How to Trade

Does Vor Biopharma (VOR) Have the Potential to Rally 117% as Wall Street Analysts Expect?

Vor Biopharma: It's A Game Of Wait And See (NASDAQ:VOR)

Vor Biopharma Inc. (VOR) Presents at TD Cowen 46th Annual Health Care Conference Transcript

Vor Biopharma Inc. (VOR) Presents at 44th Annual J.P. Morgan Healthcare Conference - Slideshow (NASDAQ:VOR) 2026-01-16

Micron Tech and Citigroup among market cap stock movers on Wednesday

Vor Biopharma、取締役会に2名の投資パートナーを追加

Vor Biopharma adds two investment partners to board of directors

Vor Biopharma (VOR): Initiating Hold Rating On Durable Telitacicept MG Study Data

TDコーウェン、Vor Biopharmaをテリタシセプトの可能性を評価して「買い」で新規カバレッジ開始

Vor Biopharma stock initiated with Buy rating at TD Cowen on promising telitacicept potential

Vor Bio、臨床試験資金調達のため1億5000万ドルの私募を実施